Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure-Reference-Cited by-同舟云学术

Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure

Published:2012-04 Issue:4 Volume:14 Page:377-386
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Jackson Colette E.¹,Myles Rachel C.¹,Tsorlalis Ioannis K.¹,Dalzell Jonathan R.¹,Spooner Richard J.²,Rodgers John R.³,Bezlyak Vladimir⁴,Greenlaw Nicola⁴,Ford Ian⁴,Cobbe Stuart M.¹,Petrie Mark C.⁵,McMurray John J.V.¹

Affiliation:

1. British Heart Foundation Cardiovascular Research Centre; University of Glasgow; 126 University Place Glasgow G12 8TA UK

2. Department of Biochemistry; Gartnavel General Hospital; Glasgow UK

3. Department of Cardiology; Glasgow Royal Infirmary; Glasgow UK

4. Robertson Centre for Biostatistics; University of Glasgow; Glasgow UK

5. Scottish National Advanced Heart Failure Service; Golden Jubilee National Hospital; Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities;Epstein;Circulation,2008

2. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

3. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum;Bloomfield;Circulation,2004

4. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy;Chow;J Am Coll Cardiol,2006

5. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction;Bloomfield;J Am Coll Cardiol,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes;European Journal of Heart Failure;2023-11-21

2. Nonclinical Cardiovascular Assessment of the Soluble Guanylate Cyclase Stimulator Vericiguat;Journal of Pharmacology and Experimental Therapeutics;2023-04-17

3. Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction;Circulation: Heart Failure;2023-04

4. Adherence to prescribed medications in patients with heart failure: insights from liquid chromatography–tandem mass spectrometry-based urine analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2020-06-29

5. The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure;ESC Heart Failure;2020-05-08